Bianca Mostert

18F-FDG PET/MRI for restaging esophageal cancer after neoadjuvant chemoradiotherapy

R. Valkema, S. Lagarde, B. Wijnhoven, 2023, Nuclear medicine communications.

Perioperative Chemotherapy for Gastro-Esophageal or Gastric Cancer: Anthracyclin Triplets versus FLOT

G. Nieuwenhuijzen, H. V. van Laarhoven, B. Wijnhoven, 2024, Cancers.

The OCT2/MATE1 Interaction Between Trifluridine, Metformin and Cimetidine: A Crossover Pharmacokinetic Study.

P. de Bruijn, R. V. van Leeuwen, K. Hussaarts, 2024, Clinical pharmacokinetics.

Induction chemotherapy followed by response evaluation and esophagectomy for advanced esophageal cancer.

R. Valkema, L. Beerepoot, S. Lagarde, 2024, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape

F. Roviello, M. Mazzei, M. I. van Berge Henegouwen, 2024, Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association.

International Expert Consensus on Semantics of Multimodal Esophageal Cancer Treatment: Delphi Study

J. V. van Sandick, J. Heisterkamp, A. Verschoor, 2024, Annals of Surgical Oncology.

Interval Metastases After Neoadjuvant Chemoradiotherapy for Patients with Locally Advanced Esophageal Cancer: A Multicenter Observational Cohort Study

J. V. van Sandick, G. Nieuwenhuijzen, P. Coene, 2024, Annals of surgical oncology.